Wird geladen...
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19
Here we report our perspective on applying GapmeR technology in combination with recombinant angiotensin-converting enzyme 2 (ACE2) in the treatment of COVID-19 patients. GapmeR is a cell-permeating antisense single-stranded DNA molecule that can be designed to specifically target intracellular seve...
Gespeichert in:
| Veröffentlicht in: | Front Mol Biosci |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7427089/ https://ncbi.nlm.nih.gov/pubmed/32850978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00197 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|